Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Synapse defective protein 1 | 0.0007 | 0.0035 | 0.0378 |
Echinococcus granulosus | C2 calcium dependent membrane targeting | 0.0007 | 0.0029 | 0.0029 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0019 | 0.028 | 0.2993 |
Echinococcus multilocularis | protein piccolo | 0.0007 | 0.0029 | 0.0029 |
Onchocerca volvulus | 0.0006 | 0 | 0.5 | |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0044 | 0.0815 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0936 | 1 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0049 | 0.0936 | 1 |
Echinococcus multilocularis | intersectin 2 | 0.0006 | 0.0007 | 0.0007 |
Brugia malayi | flavodoxin family protein | 0.0049 | 0.0936 | 1 |
Echinococcus granulosus | methionine synthase reductase | 0.003 | 0.053 | 0.053 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0019 | 0.028 | 1 |
Onchocerca volvulus | Putative cc2d1b protein | 0.0006 | 0 | 0.5 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.003 | 0.053 | 0.5659 |
Onchocerca volvulus | 0.0006 | 0 | 0.5 | |
Plasmodium vivax | flavodoxin domain containing protein | 0.0044 | 0.0815 | 0.871 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0024 | 0.0401 | 0.4283 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0049 | 0.0936 | 1 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0019 | 0.028 | 0.2993 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0049 | 0.0936 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0019 | 0.028 | 0.2993 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0019 | 0.028 | 1 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0019 | 0.028 | 0.2993 |
Brugia malayi | FAD binding domain containing protein | 0.003 | 0.053 | 0.5659 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0049 | 0.0936 | 0.0936 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0049 | 0.0936 | 1 |
Onchocerca volvulus | 0.0006 | 0 | 0.5 | |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0044 | 0.0815 | 0.871 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.003 | 0.053 | 0.5659 |
Trypanosoma cruzi | p450 reductase, putative | 0.0049 | 0.0936 | 1 |
Echinococcus multilocularis | C2 calcium dependent membrane targeting | 0.0007 | 0.0029 | 0.0029 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0024 | 0.0401 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0019 | 0.028 | 0.2993 |
Loa Loa (eye worm) | hypothetical protein | 0.0007 | 0.0029 | 0.0311 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0025 | 0.0409 | 0.4369 |
Chlamydia trachomatis | sulfite reductase | 0.003 | 0.053 | 0.5 |
Leishmania major | cytochrome P450 reductase, putative | 0.0044 | 0.0815 | 0.871 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0049 | 0.0936 | 1 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0019 | 0.028 | 0.2993 |
Brugia malayi | Synapse defective protein 1 | 0.0006 | 0.0006 | 0.0067 |
Onchocerca volvulus | 0.0006 | 0 | 0.5 | |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0049 | 0.0936 | 1 |
Schistosoma mansoni | rho gtpase activating protein | 0.0006 | 0.0006 | 0.0067 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0019 | 0.028 | 0.2993 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0019 | 0.028 | 0.2993 |
Schistosoma mansoni | regulator of G protein signaling 3 rgs3 | 0.0007 | 0.0029 | 0.0311 |
Echinococcus granulosus | intersectin 2 | 0.0006 | 0.0007 | 0.0007 |
Brugia malayi | C2 domain containing protein | 0.0007 | 0.0029 | 0.0311 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0019 | 0.028 | 0.2993 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0049 | 0.0936 | 1 |
Echinococcus multilocularis | active breakpoint cluster region | 0.047 | 1 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0049 | 0.0936 | 1 |
Treponema pallidum | flavodoxin | 0.0019 | 0.028 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0024 | 0.0401 | 1 |
Onchocerca volvulus | 0.0006 | 0 | 0.5 | |
Onchocerca volvulus | 0.0006 | 0 | 0.5 | |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0049 | 0.0936 | 1 |
Onchocerca volvulus | Multiple C2 domain and transmembrane region protein homolog | 0.0006 | 0 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0019 | 0.028 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0019 | 0.028 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0049 | 0.0936 | 0.5 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0049 | 0.0936 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0049 | 0.0936 | 0.0936 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0019 | 0.028 | 0.2993 |
Echinococcus multilocularis | methionine synthase reductase | 0.003 | 0.053 | 0.053 |
Onchocerca volvulus | 0.0006 | 0 | 0.5 | |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0049 | 0.0936 | 0.0936 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0019 | 0.028 | 0.2993 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0019 | 0.028 | 0.2993 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0049 | 0.0936 | 0.0936 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0019 | 0.028 | 1 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0049 | 0.0936 | 1 |
Onchocerca volvulus | 0.0006 | 0 | 0.5 | |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0019 | 0.028 | 0.2993 |
Brugia malayi | FAD binding domain containing protein | 0.0049 | 0.0936 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0049 | 0.0936 | 1 |
Leishmania major | p450 reductase, putative | 0.0049 | 0.0936 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0049 | 0.0936 | 1 |
Giardia lamblia | Hypothetical protein | 0.0044 | 0.0815 | 0.5 |
Brugia malayi | flavodoxin family protein | 0.0019 | 0.028 | 0.2993 |
Schistosoma mansoni | rab3 interacting molecule (rim)-related | 0.0007 | 0.0029 | 0.0311 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | < 35 % | In vitro for inhibition of HIV-1 reverse transcriptase at 1 microM | ChEMBL. | 7537334 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.